Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

38.15 

0.65 1.7%

as of Mar 26 '19

52 Week Range:

23.76 40.57


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others. It offers endoscopic video imaging systems, gastrointestinal/colono/duodeno/broncho endoscopes, endoscopic ultrasound systems, ultrasound endoscopes/probes, ultrasound centers, capsule endoscopy systems, integrated documentation systems, therapeutic equipment, and ancillary products, as well as cleaning, disinfecting, and sterilization systems; endoscopy products for gastroenterological surgery, bronchial surgery, urology, gynecology, orthopedic surgery, neurosurgery, and anesthesiology, as well as ear, nose, and throat; and therapeutic and surgical equipment, endoscope ancillary equipment, and endotherapy devices. The company also provides biological microscopes systems, such as upright, polarizing, inverted, laser scanning confocal, stereo, and marco fluorescence microscopes, as well as microscope digital cameras, life science imaging software, bio-imaging systems, and virtual slide systems; metallurgical, semiconductor and flat-panel display inspection, laser scanning, and measuring microscopes, as well as microscopic 3D measurement instruments, and industrial microscope ancillary equipment; and industrial videoscopes and fiberscopes, industrial rigidscopes, ultrasonic flaw detectors, eddy current and phased array flaw detectors, and X-ray fluorescence and X-ray diffraction analyzers. In addition, it offers interchangeable lens cameras, compact digital cameras, digital camera accessories, lens barrels units, optical components, digital audio recorders, and binoculars, as well as related software applications; and biomedical materials and conducts system. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '08 Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Equity (BVPS) 8.34
4.60
6.22
5.22
1.39
2.44
6.75
9.37
9.13
10.28
10.07
growth rate -44.8% 35.2% -16.1% -73.4% 75.5% 176.6% 38.8% -2.6% 12.6% -2.0%
Earnings BIT 681.19
-657.36
620.64
163.87
-68.40
137.81
73,445.00
91,712.00
104,464.00
76,487.00
79,720.00
growth rate -100.0% 100.0% -73.6% -100.0% 100.0% 53,195.2% 24.9% 13.9% -26.8% 4.2%
Avg.PE 13.91
0.00
16.78
84.03
0.00
76.34
79.37
14.04
14.04
16.04
18.83
growth rate -100.0% 400.8% -100.0% 4.0% -82.3% 0.0% 14.3% 17.4%
ROA 4.73
-9.32
4.23
0.67
-4.83
0.83
1.37
-0.83
6.01
7.85
5.79
growth rate -100.0% 100.0% -84.2% -100.0% 100.0% 65.1% -100.0% 100.0% 30.6% -26.2%
ROE 16.79
-44.35
25.76
3.96
-46.99
8.27
5.69
-2.55
16.95
19.26
13.09
growth rate -100.0% 100.0% -84.6% -100.0% 100.0% -31.2% -100.0% 100.0% 13.6% -32.0%
ROIC 7.09
-11.41
6.58
1.86
-5.23
1.94
3.06
-2.32
9.71
11.94
8.58
growth rate -100.0% 100.0% -71.7% -100.0% 100.0% 57.7% -100.0% 100.0% 23.0% -28.1%
Cur. Ratio 0.82
1.39
1.60
1.64
1.64
1.71
2.09
1.54
1.95
2.01
1.68
growth rate 69.5% 15.1% 2.5% 0.0% 4.3% 22.2% -26.3% 26.6% 3.1% -16.4%
Quick Ratio 0.53
0.90
1.12
1.14
1.15
1.12
1.39
0.96
1.15
1.22
1.16
growth rate 69.8% 24.4% 1.8% 0.9% -2.6% 24.1% -30.9% 19.8% 6.1% -4.9%
Leverage 3.81
6.85
5.50
6.50
21.59
6.44
3.11
3.04
2.61
2.31
2.21
growth rate 79.8% -19.7% 18.2% 232.2% -70.2% -51.7% -2.3% -14.1% -11.5% -4.3%
Balance Sheet Mar '08 Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Acct.Receivable 189,775.00
155,664.00
151,503.00
138,528.00
147,496.00
143,711.00
152,301.00
175,541.00
167,641.00
167,542.00
161,466.00
growth rate -18.0% -2.7% -8.6% 6.5% -2.6% 6.0% 15.3% -4.5% -0.1% -3.6%
Acct.Payable 42,272.00
45,409.00
39,155.00
40,597.00
41,596.00
57,559.00
growth rate 7.4% -13.8% 3.7% 2.5% 38.4%
Cur.Assets 507,189.00
474,767.00
532,876.00
533,534.00
526,558.00
541,037.00
576,512.00
577,528.00
520,692.00
552,992.00
514,291.00
growth rate -6.4% 12.2% 0.1% -1.3% 2.8% 6.6% 0.2% -9.8% 6.2% -7.0%
Total Assets 1,217,172.00
7,854.86
8,296.03
7,337.95
6,958.99
960,082.00
1,027,475.00
1,081,551.00
1,000,614.00
991,062.00
978,663.00
growth rate -99.4% 5.6% -11.6% -5.2% 13,696.3% 7.0% 5.3% -7.5% -1.0% -1.3%
Cash 123,284.00
971.83
1,488.84
1,537.64
1,440.63
229,610.00
252,121.00
209,875.00
166,554.00
199,431.00
191,239.00
growth rate -99.2% 53.2% 3.3% -6.3% 15,838.1% 9.8% -16.8% -20.6% 19.7% -4.1%
Inventory 110,379.00
95,540.00
89,959.00
92,929.00
102,493.00
99,307.00
98,595.00
107,387.00
111,558.00
124,064.00
139,309.00
growth rate -13.4% -5.8% 3.3% 10.3% -3.1% -0.7% 8.9% 3.9% 11.2% 12.3%
Cur.Liabilities 644,872.00
341,905.00
332,442.00
332,772.00
320,393.00
316,860.00
276,306.00
374,793.00
266,625.00
274,729.00
305,920.00
growth rate -47.0% -2.8% 0.1% -3.7% -1.1% -12.8% 35.6% -28.9% 3.0% 11.4%
Liabilities 984,339.00
6,656.49
6,734.42
6,505.78
6,613.19
807,675.00
696,191.00
724,297.00
616,331.00
560,182.00
534,404.00
growth rate -99.3% 1.2% -3.4% 1.7% 12,113.1% -13.8% 4.0% -14.9% -9.1% -4.6%
LT Debt 282,768.00
3,854.28
3,942.06
3,753.01
3,818.24
422,880.00
346,814.00
253,286.00
264,482.00
217,505.00
159,183.00
growth rate -98.6% 2.3% -4.8% 1.7% 10,975.3% -18.0% -27.0% 4.4% -17.8% -26.8%
Equity 232,833.00
1,198.37
1,561.62
832.17
345.80
1,093.73
329,634.00
355,722.00
382,787.00
429,361.00
442,793.00
growth rate -99.5% 30.3% -46.7% -58.5% 216.3% 30,038.5% 7.9% 7.6% 12.2% 3.1%
Common Shares 270.00
268.00
270.00
269.00
267.00
277.00
332.00
342.00
342.00
342.00
342.00
growth rate -0.7% 0.8% -0.4% -0.7% 3.8% 19.9% 3.0% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '08 Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Capital Expenditures 47,953.00
311.19
284.39
145.75
163.88
24,023.00
27,342.00
35,955.00
50,422.00
43,542.00
48,855.00
growth rate -99.4% -8.6% -48.8% 12.4% 14,559.0% 13.8% 31.5% 40.2% -13.6% 12.2%
Cash Dividends 11,893.00
76.32
29.16
58.31
28.83
0.00
3,422.00
3,422.00
3,422.00
5,818.00
9,583.00
growth rate -99.4% -61.8% 100.0% -50.6% -100.0% 0.0% 0.0% 70.0% 64.7%
Cash From OA 88,205.00
295.56
548.96
219.38
222.40
25,233.00
72,388.00
66,811.00
48,621.00
90,194.00
95,146.00
growth rate -99.7% 85.7% -60.0% 1.4% 11,245.7% 186.9% -7.7% -27.2% 85.5% 5.5%
FCF per Share 0.96
-0.22
0.93
0.10
0.54
-0.58
0.42
0.89
0.89
-0.50
0.67
growth rate -100.0% 100.0% -89.3% 440.0% -100.0% 100.0% 111.9% 0.0% -100.0% 100.0%
Sale Purchase of Stock 112,661.00
growth rate
FCF 41,053.00
-7,818.00
31,347.00
3,293.00
-4,355.00
-2,732.00
39,804.00
25,713.00
-7,788.00
42,944.00
31,737.00
growth rate -100.0% 100.0% -89.5% -100.0% 0.0% 100.0% -35.4% -100.0% 100.0% -26.1%
Income Statement Mar '08 Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Sales 1,128,875.00
6,963.70
6,358.22
6,099.16
6,109.55
743,851.00
713,286.00
764,671.00
804,578.00
748,050.00
786,497.00
growth rate -99.4% -8.7% -4.1% 0.2% 12,075.2% -4.1% 7.2% 5.2% -7.0% 5.1%
Op.Income 102,581.00
245.57
433.07
276.33
255.73
8,242.00
73,445.00
91,712.00
104,464.00
76,487.00
79,720.00
growth rate -99.8% 76.4% -36.2% -7.5% 3,122.9% 791.1% 24.9% 13.9% -26.8% 4.2%
IBT 91,178.00
-648.24
620.67
143.55
-68.36
137.82
16,425.00
8,934.00
70,800.00
81,686.00
76,665.00
growth rate -100.0% 100.0% -76.9% -100.0% 100.0% 11,817.5% -45.6% 692.5% 15.4% -6.2%
Net Income 54,624.00
-815.15
343.89
31.05
-351.19
8,242.00
13,627.00
-8,737.00
62,594.00
78,191.00
57,064.00
growth rate -100.0% 100.0% -91.0% -100.0% 100.0% 65.3% -100.0% 100.0% 24.9% -27.0%
EPS 214.44
-428.83
177.22
14.39
-183.54
28.96
41.04
-25.53
182.84
124.96
166.76
growth rate -100.0% 100.0% -91.9% -100.0% 100.0% 41.7% -100.0% 100.0% -31.7% 33.5%
Gross Profit 509,504.00
3,274.68
2,939.36
2,791.33
2,763.40
378,198.00
440,456.00
489,851.00
535,237.00
491,342.00
510,484.00
growth rate -99.4% -10.2% -5.0% -1.0% 13,586.0% 16.5% 11.2% 9.3% -8.2% 3.9%
R&D 29,174.00
35,697.00
41,753.00
39,784.00
growth rate 22.4% 17.0% -4.7%

Quarterly Statements

Item Name Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Earnings BIT 22,335.00
19,785.00
-11,631.00
14,401.00
17,467.00
growth rate -11.4% -100.0% 100.0% 21.3%
Balance Sheet Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Acct.Receivable 160,519.00
161,466.00
145,589.00
154,187.00
146,862.00
growth rate 0.6% -9.8% 5.9% -4.8%
Acct.Payable 59,622.00
57,559.00
55,442.00
53,846.00
54,103.00
growth rate -3.5% -3.7% -2.9% 0.5%
Cur.Assets 517,554.00
514,291.00
506,817.00
459,631.00
458,466.00
growth rate -0.6% -1.5% -9.3% -0.3%
Total Assets 991,613.00
978,663.00
981,978.00
939,372.00
922,613.00
growth rate -1.3% 0.3% -4.3% -1.8%
Cash 186,713.00
191,239.00
189,925.00
130,850.00
130,934.00
growth rate 2.4% -0.7% -31.1% 0.1%
Inventory 147,115.00
139,309.00
146,376.00
152,147.00
154,879.00
growth rate -5.3% 5.1% 3.9% 1.8%
Cur.Liabilities 297,365.00
305,920.00
355,722.00
300,666.00
284,700.00
growth rate 2.9% 16.3% -15.5% -5.3%
Liabilities 538,050.00
534,404.00
560,859.00
496,925.00
483,929.00
growth rate -0.7% 5.0% -11.4% -2.6%
LT Debt 173,138.00
159,183.00
132,989.00
123,721.00
122,739.00
growth rate -8.1% -16.5% -7.0% -0.8%
Equity 452,014.00
442,793.00
419,821.00
441,216.00
437,452.00
growth rate -2.0% -5.2% 5.1% -0.9%
Common Shares 124,560.00
124,560.00
124,560.00
124,606.00
124,606.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Capital Expenditures 12,730.00
13,760.00
11,584.00
11,934.00
10,645.00
growth rate 8.1% -15.8% 3.0% -10.8%
Cash Dividends 9,167.00
9,167.00
9,167.00
392.00
growth rate 0.0% 0.0% -95.7%
Cash From OA 17,607.00
34,927.00
25,028.00
2,416.00
9,143.00
growth rate 98.4% -28.3% -90.4% 278.4%
FCF 4,877.00
21,167.00
13,444.00
-9,518.00
-1,502.00
growth rate 334.0% -36.5% -100.0% 0.0%
Income Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Sales 202,633.00
214,433.00
180,554.00
201,295.00
199,197.00
growth rate 5.8% -15.8% 11.5% -1.0%
Op.Income 22,335.00
19,785.00
-11,631.00
14,401.00
17,467.00
growth rate -11.4% -100.0% 100.0% 21.3%
IBT 20,544.00
20,961.00
-14,708.00
11,927.00
16,366.00
growth rate 2.0% -100.0% 100.0% 37.2%
Net Income 18,199.00
9,027.00
-16,685.00
11,191.00
12,021.00
growth rate -50.4% -100.0% 100.0% 7.4%
EPS
growth rate
Gross Profit 131,155.00
137,573.00
118,349.00
130,498.00
129,557.00
growth rate 4.9% -14.0% 10.3% -0.7%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (55.33)

YOY Growth Grade:

F (13.75)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 41.57 47.39 200.21
EPS / Growth 0.81

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 50.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 40.0% 50.0% 83.5%
Future PE 41.57 113.93 136.25
Future EPS 23.29 46.42 348.27
Value Price
MOS %
239.26
527.2%
1,307.24
3,326.6%
11,729.74
30,646.4%
MOS Price 119.63 653.62 5,864.87
IRT 7.95 6.95 5.10

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.